CT SB00415 | 2022 | General Assembly
Status
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on March 10 2022 - 25% progression, died in committee
Action: 2022-03-11 - Public Hearing 03/17
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 10 2022 - 25% progression, died in committee
Action: 2022-03-11 - Public Hearing 03/17
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To (1) prohibit certain health carriers from requiring the use of step therapy for drugs prescribed to treat behavioral health conditions or chronic, disabling or life-threatening conditions or diseases; (2) redefine "clinical peer" for the purposes of adverse determination and utilization reviews; (3) require health carriers to bear the burden of proving that certain health care services under adverse determination or utilization review are not medically necessary; and (4) require health carriers to provide certain clinical peers with authority to reverse initial adverse determinations.
Title
An Act Concerning Step Therapy, Adverse Determination And Utilization Reviews.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2022-03-11 | Senate | Public Hearing 03/17 |
| 2022-03-10 | Senate | Referred to Joint Committee on Insurance and Real Estate |
Connecticut State Sources
| Type | Source |
|---|---|
| Summary | https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00415&which_year=2022 |
| Text | https://www.cga.ct.gov/2022/TOB/S/PDF/2022SB-00415-R00-SB.PDF |
